New Paper by first author Ashley I. Michnick titled “Sequential Safety Surveillance of RSVpreF Vaccination During Pregnancy Early After Vaccine Approval” published in JAMA Network Open.
A new study led by @deptpopmed.bsky.social found that patients who received the RSV vaccine ABRYSVO™ during pregnancy had no increased risk of preterm birth. The study also identified hincreased risk of high blood pressure in pregnancy and waters breaking before labor.
Study: tinyurl.com/7847eyaf